The Kyoto City Venture Enterprise Screening Committee is a program established by the City of Kyoto to discover and nurture venture companies that will drive the industries of the next generation, comprehensively evaluating new business plans based on criteria such as novelty, business viability, market potential, and management philosophy. In this screening, we received high recognition for the novelty and innovation of our proprietary RN-501 technology, as well as the uniqu

RadioNano Therapeutics Inc. has been selected for the Grand Prize in the “22nd Innovation Research and Development Grant Program,” hosted by Ikeda Senshu Bank, Ltd. This grant program aims to revitalize local communities by supporting advanced research and development plans that contribute to solving social and regional issues, thereby fostering the creation of new businesses. Our company will continue to strive toward the social implementation of our novel boron‑containing n

Our company has been selected as one of the “100 Japanese Startups to Watch in 2026,” published in the January 2026 issue of Forbes JAPAN, released on November 25, 2025. Publication:  Forbes JAPAN “Japan’s Top Entrepreneurs BEST10”  January 2026 Issue No.137 Release Date:  Tuesday, November 25, 2025 Featured Article:   “Rising Stars Leading the Era: 100 Japanese Startups to Watch in 2026” Official Website:   https://forbesjapan.com/

The 5th Annual Meeting of the Japanese Society for Quantum Medical Science (Dates: November 14-15, 2025; Venue: Kyushu University) featured a luncheon seminar co-hosted with TAE Life Sciences. At the luncheon seminar, Professor Komatsu of Kyoto University delivered a well-received lecture titled “From Molecules to Nanoparticles: The Paradigm Shift in BNCT,” detailing the research journey and achievements leading to the development of RN-501.

Our company was featured in one of the “Ichi-Oshi” articles. NIKKEI Biotechnology and Business (December 26, 2024） The reporter's top...

RadioNano Therapeutics Inc. has announced that it has raised around 150 million yen by Kyoto Capital Partners Co., Ltd. , Chushin Venture...

An article introducing our company was published. NIKKEI Biotechnology and Business (October 30, 2024） Venture Explorations「RadioNano...